Immunogenomics to accelerate immunotherapy—new solutions for T-cell and B-cell receptor profiling

Development of monoclonal antibodies, vaccines, and immune cell-based therapies are instrumental in fighting infectious diseases and immune-related diseases like cancer. A better understanding of the diversity of T-cell and B-cell receptors (TCRs and BCRs) is key to gaining insights into the adaptive immune response in healthy individuals and those with a wide range of diseases.